CJ Bioscience, Inc. (KOSDAQ:311690)
South Korea
· Delayed Price · Currency is KRW
10,220
+140 (1.39%)
Last updated: Apr 28, 2025
CJ Bioscience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Apr '25 Apr 25, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 133,268 | 131,831 | 147,076 | 170,481 | 286,048 | 199,288 | |
| Market Cap Growth | -10.37% | -10.37% | -13.73% | -40.40% | 43.54% | 39.15% | |
| Enterprise Value | 67,310 | 98,118 | 116,989 | 139,502 | 291,080 | 185,214 | |
| Last Close Price | 10200.00 | 10090.00 | 16140.00 | 24887.51 | 41793.85 | 43939.33 | |
| PS Ratio | 38.44 | 38.03 | 26.38 | 41.84 | 65.56 | 37.52 | |
| PB Ratio | 1.71 | 1.70 | 2.06 | 3.43 | 3.26 | 5.78 | |
| P/TBV Ratio | 2.04 | 2.02 | 2.49 | 3.51 | 3.26 | 5.80 | |
| EV/Sales Ratio | 19.42 | 28.30 | 20.98 | 34.24 | 66.72 | 34.87 | |
| Debt / Equity Ratio | 0.12 | 0.12 | 0.12 | 0.58 | 0.27 | 1.04 | |
| Asset Turnover | 0.04 | 0.04 | 0.06 | 0.04 | 0.05 | 0.10 | |
| Inventory Turnover | 22.21 | 22.21 | 32.50 | 24.90 | 10.67 | 13.27 | |
| Quick Ratio | 4.10 | 4.10 | 4.38 | 1.43 | 3.39 | 13.19 | |
| Current Ratio | 4.14 | 4.14 | 4.43 | 1.46 | 3.42 | 13.68 | |
| Return on Equity (ROE) | -44.00% | -44.00% | -37.82% | -50.78% | -31.51% | -26.82% | |
| Return on Assets (ROA) | -22.44% | -22.44% | -21.95% | -20.00% | -6.66% | -9.94% | |
| Return on Capital (ROIC) | -25.61% | -25.61% | -25.26% | -21.82% | -6.94% | -10.45% | |
| Earnings Yield | -24.64% | -24.91% | -15.58% | -20.48% | -6.74% | -4.40% | |
| FCF Yield | -21.11% | -21.34% | -20.28% | -14.73% | -3.28% | -10.03% | |
| Buyback Yield / Dilution | -30.93% | -30.93% | -20.52% | -38.23% | -10.14% | -16.93% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.